U.S. Markets closed

Why Novartis’s Entresto Could Witness a Robust Demand Trend in 2018

Margaret Patrick
Why Novartis’s Entresto Could Witness a Robust Demand Trend in 2018

For 4Q17, Novartis’s (NVS) Entresto reported sales of $185 million around the world, which represents a YoY (year-over-year) rise of 172% on a reported basis and a 164% YoY rise on a CC (constant currency) basis. Novartis reported Entresto sales of ~$507 million for fiscal 2017, which represents a YoY rise of ~198% on a reported basis. Novartis has now launched Entresto in almost 60 countries worldwide, with its latest launch just completed in China.